Dubai, United Arab Emirates, 31 December 2024, Chainwire
Decentralized Science (DeSci) aims to address systemic inefficiencies in traditional scientific research, such as bureaucratic funding processes, underfunded breakthrough opportunities, and limited retail access to long-lived investments.
SUI Desci Agents, a platform that enables the retail audience to invest in discoveries in longevity research, is poised to become a flagship project at the forefront of the upcoming trend.
Binance list of BIO protocols
On December 23, 2024, Binance posted a tweet announcing the launch of the BIO Protocol launch party.
Now, users can stake their BNB and FDUSD to earn BIO airdrops over 10 days, with the Binance BIO protocol listing scheduled for January 3, 2025.
SUI DeSci agents at the head of DeSci
SUI Desci Agents is a platform for launching DeSci assets, automatically growing their audience using AI agents and generating liquidity using mechanics inspired by pump.fun. It aims to democratize access to longevity research investments for retail customers.
$DESCI offers a number of features that make the project unique:
- Tokenized compounds: users can bet on the potential of long-lived compounds such as Epitalon and Rapamycin (the first compounds to launch) by viewing their scientific data and statistics.
- Matchmaking AI Agents: LLM-trained AI agents are paired with longevity matches and promote them 24/7 on social platforms, ensuring effective outreach.
- Layer 2 Liquidity Mechanics: Pairing $DESCI tokens with compounds creates a robust liquidity ecosystem tailored for DeSci.
- B2C products powered by artificial intelligence: Wellness tools attract millions of health enthusiasts, drive organic growth and support the ecosystem.
The number of DeSci supporters is constantly growing
The number of DeSci supporters continues to grow and includes prominent web3 leaders and major web2 VC firms:
- Vitalik Buterin emphasized the transformative potential of DeSci projects at the recent Devcon event.
- Coinbase founder Brian Armstrong supports ResearchHub to encourage open scientific collaboration.
- A16Z led a $5 million funding round for AminoChain, a decentralized biospecimen marketplace.
- Pfizer Ventures participated in a $4.1 million funding round for VitaDAO, a project aimed at raising funds for research that extends human life.
2025: The Year of $DeSci
In November 2024, pump.science launched two tokens, Rifampicin and Urolithin A, which have since attracted market attention. Their market capitalization reached approximately $125 million and $45 million, respectively, within days of the launch.
The decentralized science (DeSci) sector continues to expand, and SUI DeSci Agents has established itself as a potential leader. The project is developing a platform where the retail audience can invest in tokenized longevity compounds. They are also working on AI-powered B2C wellness tools that would help SUI Desci Agents engage more users in the ecosystem.
As interest in a decentralized approach to science grows, $DESCI aims to contribute to the evolution of scientific innovation.
About SUI DeSci agents
The SUI DeSci Agents platform is designed to launch DeSci assets, grow their audience using AI agents and create liquidity through advanced mechanics inspired by pump.fun.
With the popular tag $DeSci, the project aims to democratize access to investing in longevity research, empowering the retail audience to actively participate in scientific advances.
Contact
CEO
Look at Zubariev
SUI Desci agents
info@desciagents.ai
